Literature DB >> 2185238

Complete primary structure of the human estrogen-responsive gene (pS2) product.

K Mori1, R Fujii, N Kida, H Takahashi, S Ohkubo, M Fujino, M Ohta, K Hayashi.   

Abstract

pS2 is a human gene whose transcription is directly triggered by estrogen in human breast cancer cells (MCF-7). We described here the complete primary structure of the pS2 gene product. The pS2 protein purified from conditioned medium of MCF-7 cells was S-pyridylethylated and digested with TPCK-trypsin. Five major fragments were obtained by reverse-phase HPLC. Amino acid sequence analysis of these tryptic peptides established that the pS2 protein comprises a 60-amino acid polypeptide. The sequence of the pS2 protein was completely identical to that deduced from the nucleotide sequence of the pS2 gene, if the signal polypeptide is excluded. Furthermore, two cDNA clones encoding an 84-amino acid precursor pS2 protein were isolated from a cDNA library which was constructed with RNA from MCF-7 cells cultured in the presence of estrogen. The nucleotide sequence of one clone (pS2B1) was identical to that of pS2 cDNA previously reported except for one nucleotide in the 3' untranslated region. The other clone (pS2B2) was longer by 73 nucleotides, at the 5' end, than pS2B1. The additional 73 nucleotides are located just upstream of the sequence of pS2B1 in the structure of the pS2 gene, indicating that the pS2 gene has two start sites for transcription. However, a mRNA molecule corresponding to pS2B1 but not to pS2B2 was detected in the cells on RNA blot hybridization analysis, indicating that one transcriptional start site is mainly used.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185238     DOI: 10.1093/oxfordjournals.jbchem.a123014

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

1.  Investigation of trefoil factor expression in saliva and oral mucosal tissues of patients with oral squamous cell carcinoma.

Authors:  Ponlatham Chaiyarit; Akasith Utrawichian; Chanvit Leelayuwat; Patrawut Vatanasapt; Nattharee Chanchareonsook; Mie Hessellund Samson; Andrew S Giraud
Journal:  Clin Oral Investig       Date:  2011-12-30       Impact factor: 3.573

2.  Hyperplastic polyps: a cell lineage which both synthesizes and secretes trefoil-peptides and has phenotypic similarity with the ulcer-associated cell lineage.

Authors:  A M Hanby; R Poulsom; S Singh; J Jankowski; D Hopwood; G Elia; L Rogers; K Patel; N A Wright
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

3.  Trefoil factor 1 elevates the malignant phenotype of mucinous ovarian cancer cell through Wnt/β-catenin signaling.

Authors:  Shan Zhao; Yumei Ma; Xianghua Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Prognostic evaluation of oestrogen-regulated protein immunoreactivity in ductal invasive (NOS) breast cancer.

Authors:  L Nakopoulou; A C Lazaris; D Baltas; I Giannopoulou; N Kavantzas; A Tzonou
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Immunohistochemical and biochemical analysis of the oestrogen regulated protein pS2, and its relation with oestrogen receptor and progesterone receptor in breast cancer.

Authors:  S Detre; N King; J Salter; K MacLennan; J A McKinna; M Dowsett
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

Review 6.  Aspects of the biology of regeneration and repair in the human gastrointestinal tract.

Authors:  N A Wright
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

7.  Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.

Authors:  Paule Héléna Yoffou; Lydia Edjekouane; Liliane Meunier; André Tremblay; Diane Michèle Provencher; Anne-Marie Mes-Masson; Euridice Carmona
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

8.  pS2 is an independent factor of good prognosis in primary breast cancer.

Authors:  A M Thompson; R A Hawkins; R A Elton; C M Steel; U Chetty; D C Carter
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

9.  Effect of Initial Periodontal Therapy on Salivary Trefoil Factor (TFF3) in otherwise Healthy Patients with Gingivitis and Chronic Periodontitis.

Authors:  Devika Meesala; Gautami S Penmetsa; C D Dwarakanath; Ravikanth Manyam
Journal:  Contemp Clin Dent       Date:  2018-06

10.  Production of Monoclonal Antibodies against Human Trefoil Factor 3 and Development of a Modified-Sandwich ELISA for Detection of Trefoil Factor 3 Homodimer in Saliva.

Authors:  Saichit Khummuang; Waraporn Phanphrom; Witida Laopajon; Watchara Kasinrerk; Ponlatham Chaiyarit; Supansa Pata
Journal:  Biol Proced Online       Date:  2017-11-08       Impact factor: 3.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.